Jiangsu Sihuan Bioengineering Co., Ltd. (000518) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jiangsu Sihuan Bioengineering Co., Ltd.

Why is Jiangsu Sihuan Bioengineering Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 0.40%

The company has been able to generate a Return on Capital Employed (avg) of 0.40% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -6.81% and Operating profit at -216.34% over the last 5 years

With a growth in Net Sales of 60.91%, the company declared Outstanding results in Sep 25

The company has declared positive results in Jan 70 after 2 consecutive negative quarters
OPERATING CASH FLOW(Y) Highest at CNY 84.71 MM
NET SALES(Q) At CNY 112.48 MM has Grown at 60.91%
CASH AND EQV(HY) Highest at CNY 134.86 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 30.80%, its profits have fallen by -116.7%

Market Beating Performance

The stock has generated a return of 30.80% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.17%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Jiangsu Sihuan Bioengineering Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jiangsu Sihuan Bioengineering Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Jiangsu Sihuan Bioengineering Co., Ltd.

28.63%

0.99

39.30%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-6.81%

EBIT Growth (5y)

-216.34%

EBIT to Interest (avg)

-20.68

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

0.55

Tax Ratio

0.71%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.40%

ROE (avg)

0.14%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.49

EV to EBIT

-26.91

EV to EBITDA

-32.59

EV to Capital Employed

7.13

EV to Sales

8.30

PEG Ratio

Dividend Yield

ROCE (Latest)

-26.49%

ROE (Latest)

-31.13%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

28What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 84.71 MM

NET SALES(Q)

At CNY 112.48 MM has Grown at 60.91%

CASH AND EQV(HY)

Highest at CNY 134.86 MM

DEBT-EQUITY RATIO (HY)

Lowest at -16.62 %

INVENTORY TURNOVER RATIO(HY)

Highest at 0.71 times

DEBTORS TURNOVER RATIO(HY)

Highest at 4.22 times

PRE-TAX PROFIT(Q)

At CNY -3.17 MM has Grown at 88.77%

NET PROFIT(Q)

At CNY -2.61 MM has Grown at 90.43%

-5What is not working for the Company

INTEREST(HY)

At CNY 1.08 MM has Grown at 46.07%

RAW MATERIAL COST(Y)

Grown by 54.68% (YoY

Here's what is working for Jiangsu Sihuan Bioengineering Co., Ltd.

Operating Cash Flow

Highest at CNY 84.71 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

At CNY 112.48 MM has Grown at 60.91%

over average net sales of the previous four periods of CNY 69.9 MM

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -3.17 MM has Grown at 88.77%

over average net sales of the previous four periods of CNY -28.27 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -2.61 MM has Grown at 90.43%

over average net sales of the previous four periods of CNY -27.26 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv

Highest at CNY 134.86 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -16.62 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 0.71 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 4.22 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Jiangsu Sihuan Bioengineering Co., Ltd.

Interest

At CNY 1.08 MM has Grown at 46.07%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Raw Material Cost

Grown by 54.68% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales